DB
NVAX icon

Danske Bank’s Novavax NVAX Stock Holding History

Danske Bank’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.64K Sell
811
-6,589
-89% -$59K ﹤0.01% 867
2026
Q1 		$60.2K Hold
7,400
– – ﹤0.01% 697
2025
Q4 		$49.7K Hold
7,400
– – ﹤0.01% 992
2025
Q3 		$64.2K Sell
7,400
-2,500
-25% -$19.5K ﹤0.01% 950
2025
Q2 		$62.4K Hold
9,900
– – ﹤0.01% 970
2025
Q1 		$63.5K Buy
9,900
+2,500
+34% +$20.7K ﹤0.01% 958
2024
Q4 		$59.5K Hold
7,400
– – ﹤0.01% 969
2024
Q3 		$93.5K Buy
7,400
+1,200
+19% +$15.5K ﹤0.01% 1026
2024
Q2 		$78.5K Hold
6,200
– – ﹤0.01% 955
2024
Q1 		$29.6K Buy
+6,200
New +$28.8K ﹤0.01% 1010

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Danske Bank's NVAX Position: Q2 2026 in Review

Danske Bank reduced its Novavax (NVAX) stake by 89% in Q2 2026, selling an estimated $59K and leaving 811 shares worth $7.64K. The position accounts for ﹤0.01% of the portfolio, ranked #867.

Danske Bank first reported a position in NVAX in Q1 2024 and has held it in 10 quarters since. The position peaked at $93.5K in Q3 2024. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Danske Bank held 811 shares of Novavax worth $7.64K as of Q2 2026.
  • Danske Bank sold 6,589 Novavax shares in Q2 2026, an estimated $59K.
  • Novavax made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #867 holding.
  • Danske Bank first reported a position in Novavax in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Novavax position peaked at $93.5K in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.